Abbott Enhances Heart Failure Care with Aspirin-Free Regimen for HeartMate 3™ Patients
ABBOTT PARK, Ill.— Abbott recently announced that the U.S. Food and Drug…
Abbott and Medtronic team up for smarter diabetes care
August 2024- Abbott announced a unique global partnership with Medtronic to collaborate…
Abbott Receives CE Mark For AVEIR™ Dual Chamber
Abbott Park- June 2024- Abbott announced it has received CE Mark in…
Continuous Glucose Monitoring: Say Goodbye to Finger Pricks
2014 was not the same as 2004, and 2024 is not the…
Abbott’s Breakthrough Dissolving Stent Receives FDA Approval
May 2024- Abbott announced that the U.S. Food and Drug Administration (FDA)…
Abbott’s FreeStyle Libre® System & GLP-1 Meds Show Synergistic Impact in Type 2 Diabetes
ABBOTT PARK, Ill., March, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new data…
Find Why FDA Advisory Committee voted in favor of ABBOTT
ABBOTT PARK, February 2024 - Abbott announced that the Circulatory System Devices…
New Study Shows Mixed Reality Technology For Blood Donation
ABBOTT PARK, Ill., Feb, 2024 /PRNewswire/ -- A new study published online and available in the February…
Mark Your Calendar: Abbott Q4 Earnings Call Coming Soon?
Abbott Park- On Wednesday, January 24, Abbott will release its financial results…
Abbott’s Strategic Partnership with mAbxience Boosts Access to Oncology and Women’s Health Biosimilars in Emerging Markets
Illinois: Abbott has announced a transformative partnership with Spain-based global biotech leader…
